Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Siemens has identified that current in-date lots of advia centaur systems insulin assay recover approximately 40% higher than the world health organization (who) 1st irp 66/304 standardization based on slope values. the slope value was 1.40 on the advia centaur and 1.42 on the advia centaur cp. corrected (re-standardized) lots will be available by may 2017.